{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T00:06:58Z","timestamp":1699747618124},"reference-count":24,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":9633,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1981,11]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>An homologous carboxy\u2010terminal specific immunoradiometric assay for human parathyroid hormone (PTH) has been developed which uses an antiserum raised in a goat against intact human PTH. This assay has been applied to the measurement of circulating PTH in man; the reference preparation was a 53\u201384 fragment prepared from native human parathyroid hormone. PTH was detectable in all the normal subjects studied (range 0\u00b71\u20130\u00b779 ng\/ml) and elevated concentrations were found in a group of patients with primary hyperparathyroidism (range 0\u00b782\u201325\u00b75 ng\/ml). Carboxy\u2010terminal hormone concentrations were particularly raised in uraemic subjects (range 1\u201302\u201352\u20135 ng\/ml) but some patients with vitamin D deficient osteomalacia had concentrations within the normal range (0\u00b75\u20132\u00b74 ng\/ml). All patients with pseudohypoparathyroidism had elevated concentrations (range 1\u00b70\u20132\u00b78 ng\/ml) and in patients with idiopathic or surgical hypoparathyroidism the concentration ranged from undetectable to 0\u00b74 ng\/ml. These results have been compared with those obtained using an amino\u2010terminal specific assay. In normal subjects carboxy\u2010terminal immuno\u2010reactive hormone concentrations were, on average, three times higher than those measured in the amino\u2010terminal assay (C:N ratio 3\u00b728). In patients with secondary hyperparathyroidism this ratio was dependent on renal function and the plasma calcium concentration. The disappearance of endogenous carboxy\u2010and amino\u2010terminal PTH from the circulation of a patient with primary hyperparathyroidism was studied. Amino\u2010terminal reactive PTH disappeared much more rapidly (t\u00bd= 1\u00b75 min) than carboxy\u2010terminal hormone (<jats:italic>t<\/jats:italic>\u00bd= 2\u00b775 h). It is hoped that the carboxy\u2010terminal specific assay described here will be of value in the further study of the secretion and metabolism of PTH.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1981.tb00686.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T13:04:43Z","timestamp":1205759083000},"page":"439-449","source":"Crossref","is-referenced-by-count":27,"title":["A CARBOXY\u2010TERMINAL SPECIFIC ASSAY FOR HUMAN PARATHYROID HORMONE"],"prefix":"10.1111","volume":"15","author":[{"given":"R. M.","family":"MANNING","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"ADAMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. E.","family":"PAPAPOULOS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H.","family":"GLEED","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. N.","family":"HENDY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"ROSENBLATT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L. H.","family":"O'RIORDAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0490521"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-28-7-1037"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5660.789"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(67)90110-8"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109245"},{"key":"e_1_2_1_7_1","first-page":"567","article-title":"Human parathyroid hormone: immunological properties of the amino\u2010terminus and of synthetic fragments","volume":"47","author":"Hendy G.N.","year":"1974","journal-title":"Clinical Science and Molecular Medicine"},{"key":"e_1_2_1_8_1","first-page":"425","volume-title":"Handbook of Radioimmunoassay","author":"Hendy G.N.","year":"1977"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108802"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00705a014"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0780049"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00619a019"},{"key":"e_1_2_1_13_1","first-page":"553","article-title":"Studies of hypoparathyroidism and pseudohypoparathyroidism","volume":"47","author":"Lewin I.G.","year":"1978","journal-title":"Quarterly Journal of Medicine"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0850161"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-104-6-1778"},{"key":"e_1_2_1_16_1","first-page":"549","article-title":"Hormonal and biochemical changes in patients successfully operated for primary hyperparathyroidism","volume":"83","author":"Muls E.","year":"1976","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.2.384"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(78)90144-0"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1980.tb01023.x"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-47-2-284"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00221a017"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-103-3-978"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1095781"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-33-6-988"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00790a021"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1981.tb00686.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1981.tb00686.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T13:33:24Z","timestamp":1699709604000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1981.tb00686.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,11]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1981,11]]}},"alternative-id":["10.1111\/j.1365-2265.1981.tb00686.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1981.tb00686.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,11]]}}}